Companies: 10,795·Total market cap: $144.5T
Cencora, Inc.

Cencora, Inc.

CORNYSEHealthcare● Active
$275.04
+$4.72(+1.75%)
Market Cap$53.5B
P/E Ratio—
52W High$377.54
52W Low$244.82
Overview

Cencora, Inc. (COR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

COR · cash on hand · updated Sep 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$4.39B▲ +36.0% vs prior year
FY · as of Sep 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$4.39B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+36.0%
vs prior fiscal year
Latest Quarter
$2.24B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: September 30, 2025

Net cash vs debt

Cash & ST Investments$4.39BCash on Hand
Total Debt$10.75BTotal Debt
Net Cash / Net Debt−$6.35BNet Debt Position
Cash vs Debt Ratio
Cash 29%Debt 71%

Cencora, Inc. carries a net debt position of $6.35B. Total debt ($10.75B) exceeds cash on hand ($4.39B). Cencora, Inc. cash vs debt ratio: 29% cash / 71% debt.

Net Cash = Cash & ST Investments − Total Debt$4.39B − $10.75B = −$6.35B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
COR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Sep 30, 2025Latest$4.39B+36.0%
Sep 30, 2024$3.23B+20.1%
Sep 30, 2023$2.69B-23.9%
Sep 30, 2022$3.53B+38.7%
Sep 30, 2021$2.55B-44.6%
COR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Cencora, Inc.
Cencora, Inc.YOU
COR
$4.39B8.2%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Cencora, Inc. (COR) cash on hand as of September 30, 2025 is $4.39B, comprising $4.39B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Cencora, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Cencora, Inc. cash reserves or cash position.

Cencora, Inc. annual cash on hand history shows increased +36.0% in 2025: increased +36.0% in 2025. Cencora, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Cencora, Inc. carries total debt of $10.75B against cash of $4.39B, resulting in a net debt position of -$6.35B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

COR cash on hand · 5 questions

As of September 30, 2025, Cencora, Inc. (COR) has $4.39B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4.39B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $2.24B. Data sourced from the annual 10-K filing via FMP.

COR cash on handCOR cash reservesCOR cash 2025how much cash does COR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Cencora, Inc. · Cencora, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: September 30, 2025